<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vermijlen D</submitter><funding>Wellcome Trust</funding><pagination>4304-14</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3915340</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>178(7)</volume><pubmed_abstract>Human Vgamma9/Vdelta2 T cells comprise a small population of peripheral blood T cells that in many infectious diseases respond to the microbial metabolite, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP), expanding to up to 50% of CD3(+) cells. This "transitional response," occurring temporally between the rapid innate and slower adaptive response, is widely viewed as proinflammatory and/or cytolytic. However, increasing evidence that different cytokines drive widely different effector functions in alphabeta T cells provoked us to apply cDNA microarrays to explore the potential pleiotropy of HMB-PP-activated Vgamma9/Vdelta2 T cells. The data and accompanying validations show that the related cytokines, IL-2, IL-4, or IL-21, each drive proliferation and comparable CD69 up-regulatio</pubmed_abstract><journal>Journal of immunology (Baltimore, Md. : 1950)</journal><pubmed_title>Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.</pubmed_title><pmcid>PMC3915340</pmcid><funding_grant_id>071534</funding_grant_id><pubmed_authors>Hayday AC</pubmed_authors><pubmed_authors>Langford C</pubmed_authors><pubmed_authors>Eberl M</pubmed_authors><pubmed_authors>Ellis P</pubmed_authors><pubmed_authors>Jomaa H</pubmed_authors><pubmed_authors>Klein A</pubmed_authors><pubmed_authors>Vermijlen D</pubmed_authors><pubmed_authors>Willimann K</pubmed_authors><pubmed_authors>Engel R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy.</name><description>Human Vgamma9/Vdelta2 T cells comprise a small population of peripheral blood T cells that in many infectious diseases respond to the microbial metabolite, (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP), expanding to up to 50% of CD3(+) cells. This "transitional response," occurring temporally between the rapid innate and slower adaptive response, is widely viewed as proinflammatory and/or cytolytic. However, increasing evidence that different cytokines drive widely different effector functions in alphabeta T cells provoked us to apply cDNA microarrays to explore the potential pleiotropy of HMB-PP-activated Vgamma9/Vdelta2 T cells. The data and accompanying validations show that the related cytokines, IL-2, IL-4, or IL-21, each drive proliferation and comparable CD69 up-regulatio</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Apr</publication><modification>2026-04-07T23:57:09.043Z</modification><creation>2026-04-07T19:20:54.081Z</creation></dates><accession>S-EPMC3915340</accession><cross_references><pubmed>17371987</pubmed><doi>10.4049/jimmunol.178.7.4304</doi></cross_references></HashMap>